Emerging new targets in ovarian cancer

被引：0
|
作者：
Kaye, S. [1 ]
机构：
[1] Royal Marsden Hosp, Sutton, Surrey, England
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70174-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [1] Exosomes: Emerging biomarkers and targets for ovarian cancer
    Tang, Maggie K. S.
    Wong, Alice S. T.
    CANCER LETTERS, 2015, 367 (01) : 26 - 33
  • [2] Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease
    Arend, Rebecca C.
    Jackson-Fisher, Amy
    Jacobs, Ira A.
    Chou, Jeffrey
    Monk, Bradley J.
    CANCER BIOLOGY & THERAPY, 2021, 22 (02) : 89 - 105
  • [3] Pathogenesis and New Therapeutic Targets of Ovarian Cancer
    Shih, Ie-Ming
    Ho, Chih-Ming
    Nakayama, Kentaro
    Salani, Ritu
    JOURNAL OF ONCOLOGY, 2012, 2012
  • [4] New emerging targets in cancer immunotherapy: the role of GITR
    Buzzatti, Giulia
    Dellepiane, Chiara
    Del Mastro, Lucia
    ESMO OPEN, 2020, 4
  • [5] New Horizons: Emerging Therapies and Targets in Thyroid Cancer
    Ringel, Matthew D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01): : E382 - E388
  • [6] New emerging targets in cancer immunotherapy: the role of neoantigens
    De Mattos-Arruda, Leticia
    Blanco-Heredia, Juan
    Aguilar-Gurrieri, Carmen
    Carrillo, Jorge
    Blanco, Julia
    ESMO OPEN, 2019, 4
  • [7] Discovery and validation of new molecular targets for ovarian cancer
    Xiu, FH
    Pei, XX
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (06) : 625 - 630
  • [8] New targets and non-cytotoxics in ovarian cancer
    Eisenhauer, E. A.
    ANNALS OF ONCOLOGY, 2006, 17 : X247 - X250
  • [9] ESMO Openspecial series on new emerging targets in cancer immunotherapy
    Lambertini, Matteo
    ESMO OPEN, 2019, 4
  • [10] LncRNAs and MiRNAs: New Targets for Resveratrol in Ovarian Cancer Research
    Chaichian, Shahla
    Bidgoli, Sepideh Arbabi
    Nikfar, Banafsheh
    Moazzami, Bahram
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (28) : 3238 - 3248
12345